Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:51 pm Sale | 2023-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | Nantahala Capital Management, LLC | 77,337 1.700% | -141,036 (-64.58%) | Filing History |
| 2024-02-14 10:18 am Purchase | 2023-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | BIOTECHNOLOGY VALUE FUND L P | 463,776 9.990% | 120,720 (+35.19%) | Filing History |
| 2024-02-14 10:02 am Sale | 2023-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management, L.P. | 62,511 1.400% | -130,889 (-67.68%) | Filing History |
| 2023-02-14 4:58 pm Sale | 2022-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | Nantahala Capital Management, LLC | 218,373 6.100% | -45,150 (-17.13%) | Filing History |
| 2023-02-14 4:23 pm Sale | 2022-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management, L.P. | 193,400 5.400% | -22,502 (-10.42%) | Filing History |
| 2022-02-15 1:09 pm Sale | 2021-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | Laurence W. Lytton | 85,416 2.500% | -81,604 (-48.86%) | Filing History |
| 2022-02-14 4:48 pm Sale | 2021-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | Omega Fund V L.P. | 62,500 1.800% | -100,262 (-61.60%) | Filing History |
| 2022-02-14 4:41 pm Purchase | 2021-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management, L.P. | 215,902 6.500% | 5,902 (+2.81%) | Filing History |
| 2022-02-14 08:30 am Purchase | 2021-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | Nantahala Capital Management, LLC | 263,523 7.900% | 263,523 (New Position) | Filing History |
| 2022-02-11 4:48 pm Sale | 2021-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | BB BIOTECH AG | 0 0.000% | -141,125 (Position Closed) | Filing History |
| 2021-12-16 5:16 pm Purchase | 2021-12-14 | 13G | CIDARA THERAPEUTICS INC CDTX | BIOTECHNOLOGY VALUE FUND L P | 343,056 10.300% | 119,981 (+53.79%) | Filing History |
| 2021-10-14 5:12 pm Purchase | 2021-10-13 | 13G | CIDARA THERAPEUTICS INC CDTX | Point72 Asset Management, L.P. | 210,000 6.300% | 210,000 (New Position) | Filing History |